TipRanks
Go Ultimate55% OFF

AXM Pharma (AXMP) Financial Statements

AXM Pharma Financial Overview

AXM Pharma's market cap is currently $40.86K. The company's EPS TTM is ―; its P/E ratio is ―; AXM Pharma has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 05Dec 04Dec 03Jun 02Jun 01
Income Statement
Total Revenue―――――
Gross Profit$ 772.37K$ 1.07M$ 3.50M―$ 1.79K
Operating Income$ -8.86M$ -13.99M$ -3.71M$ -21.04K$ -148.75K
EBITDA$ -8.80M$ -13.96M$ -3.66M$ -20.15K$ -143.72K
Net Income$ -11.09M$ -13.99M$ -3.71M$ -21.04K$ -148.67K
Balance Sheet
Cash & Short-Term Investments―――――
Total Assets$ 13.73M$ 12.34M$ 11.02M$ 0.00$ 12.52K
Total Debt$ 5.02M$ 1.00M$ 0.00$ 0.00$ 0.00
Net Debt$ 4.92M$ -254.01K$ -2.95M$ 0.00$ 0.00
Total Liabilities$ 9.64M$ 5.35M$ 2.96M$ 2.63K$ 1.52K
Stockholders' Equity―――――
Cash Flow
Free Cash Flow$ -9.07M$ -10.48M$ -2.04M$ 0.00$ -106.34K
Operating Cash Flow―――――
Investing Cash Flow―――――
Financing Cash Flow―――――

Currency in USD